Profile data is unavailable for this security.
About the company
Haemonetics Corporation is a healthcare company. The Company provides a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Its technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Its segments include Plasma, Blood Center and Hospital. Its Plasma segment offers automated plasma collection and donor management software systems that improve the donor experience at plasma collection centers. Its Blood Center segment offers a range of solutions that improve donor collection centers' ability to acquire blood, filter blood and separate blood components. Its Hospital segment provides the patient care. It markets and sells its products to biopharmaceutical companies, blood collection groups and independent blood centers, hospitals and hospital service providers, group purchasing organizations and national health organizations.
- Revenue in USD (TTM)993.20m
- Net income in USD43.38m
- Incorporated1985
- Employees2.82k
- LocationHaemonetics Corp125 Summer StreetBOSTON 02110United StatesUSA
- Phone+1 (781) 848-7100
- Websitehttps://www.haemonetics.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Owens & Minor, Inc. | 9.88bn | 153.99m | 2.54bn | 6.90k | 16.41 | 2.64 | 8.56 | 0.2569 | 2.03 | 2.03 | 129.95 | 12.59 | 2.16 | 5.43 | 13.32 | 1,431,346.00 | 3.37 | -0.4021 | 5.01 | -0.6594 | 15.96 | 13.34 | 1.56 | -0.1501 | 0.5791 | 4.55 | 0.7281 | -- | 15.39 | 0.1270 | 151.59 | 15.54 | 10.53 | -60.35 |
| NuVasive, Inc. | 1.17bn | -40.07m | 2.67bn | 2.90k | -- | 3.23 | 24.55 | 2.27 | -0.8392 | -0.8392 | 21.54 | 15.88 | 0.5435 | 1.03 | 5.21 | 404,870.30 | -1.85 | 0.3758 | -2.34 | 0.4499 | 71.29 | 72.00 | -3.41 | 0.6706 | 0.7009 | 3.35 | 0.5184 | 0.00 | 8.41 | 3.43 | -72.49 | -- | 3.59 | -- |
| Inmode Ltd | 404.18m | 172.43m | 2.94bn | 362.00 | 17.60 | 6.49 | 16.98 | 7.27 | 2.01 | 2.01 | 4.71 | 5.45 | 0.892 | 2.74 | 20.46 | 1,116,530.00 | 38.05 | 37.64 | 42.78 | 45.48 | 84.04 | 85.26 | 42.66 | 38.01 | 8.27 | 377.33 | 0.00 | 0.00 | 73.49 | 72.99 | 119.87 | 245.31 | 37.94 | -- |
| Patterson Companies, Inc. | 6.50bn | 203.21m | 2.94bn | 7.70k | 14.66 | 2.81 | 10.37 | 0.4529 | 2.06 | 2.06 | 66.00 | 10.77 | 2.37 | 6.78 | 14.50 | 844,078.60 | 7.34 | -0.1828 | 11.92 | -0.2691 | 20.59 | 21.18 | 3.10 | -0.0968 | 0.8796 | -- | 0.3317 | -- | 9.93 | 3.05 | 30.28 | 3.18 | -4.02 | 1.20 |
| Conmed Corp | 1.04bn | -113.92m | 2.97bn | 3.80k | -- | -- | -- | 2.85 | -3.93 | -3.93 | 33.58 | -- | -- | -- | -- | 274,293.20 | -- | 2.11 | -- | 2.36 | 56.21 | 55.04 | -10.93 | 3.66 | -- | 4.16 | -- | 69.26 | 17.18 | 5.77 | 557.16 | 33.65 | 0.1527 | 0.00 |
| Adapthealth Corp | -100.00bn | -100.00bn | 2.99bn | 10.70k | -- | 1.40 | -- | -- | -- | -- | -- | 15.92 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.15 | -- | 0.5072 | -- | 132.35 | -- | 187.73 | -- | -- | -- |
| Helen of Troy Limited | 2.19bn | 191.39m | 3.13bn | 2.15k | 16.58 | 2.30 | 13.65 | 1.43 | 7.87 | 7.87 | 90.20 | 56.60 | 0.7976 | 2.14 | 4.96 | 1,020,601.00 | 6.97 | 9.67 | 8.87 | 12.18 | 43.52 | 42.63 | 8.74 | 10.40 | 0.9329 | 19.29 | 0.449 | -- | 5.93 | 9.73 | -8.51 | 9.17 | 38.15 | -- |
| LivaNova PLC | 1.02bn | -31.37m | 3.26bn | 3.00k | -- | 2.54 | 178.84 | 3.21 | -0.6202 | -0.6202 | 19.10 | 23.96 | 0.43 | 2.41 | 5.67 | 339,201.70 | -1.32 | -5.98 | -1.66 | -7.34 | 70.80 | 65.94 | -3.07 | -14.04 | 2.47 | 1.05 | 0.2666 | -- | 10.82 | 1.42 | 60.90 | -- | -7.86 | -- |
| Axonics Inc | 217.45m | -76.53m | 3.40bn | 517.00 | -- | 7.44 | -- | 15.63 | -1.70 | -1.70 | 4.82 | 9.29 | 0.4028 | 1.05 | 7.04 | 420,595.80 | -14.18 | -25.46 | -14.93 | -28.70 | 68.99 | 62.16 | -35.19 | -86.62 | 8.53 | -72.05 | 0.00 | -- | 61.64 | -- | -45.80 | -- | 50.57 | -- |
| Merit Medical Systems, Inc. | 1.12bn | 58.42m | 3.44bn | 6.45k | 59.65 | 3.20 | 24.37 | 3.08 | 1.01 | 1.01 | 19.38 | 18.91 | 0.6817 | 2.86 | 7.15 | 173,115.70 | 3.57 | 1.60 | 4.07 | 1.80 | 45.28 | 43.92 | 5.24 | 2.56 | 1.33 | 20.55 | 0.1865 | 0.00 | 11.50 | 12.22 | 592.27 | 19.22 | -2.57 | -- |
| Tandem Diabetes Care Inc | 765.79m | -13.17m | 3.46bn | 2.00k | -- | 7.64 | 3,709.95 | 4.52 | -0.2091 | -0.2091 | 11.89 | 7.04 | 0.8361 | 4.68 | 8.32 | 382,896.00 | -1.44 | -15.69 | -1.66 | -19.84 | 52.69 | 52.00 | -1.72 | -15.67 | 5.36 | -1.35 | 0.3858 | -- | 40.89 | 52.85 | 145.27 | -- | 21.36 | -- |
| Haemonetics Corporation | 993.20m | 43.38m | 3.47bn | 2.82k | 80.13 | 4.61 | 24.57 | 3.49 | 0.8435 | 0.8435 | 19.37 | 14.66 | 0.5398 | 1.58 | 6.92 | 352,072.30 | 2.36 | 4.59 | 2.91 | 5.78 | 51.12 | 48.09 | 4.37 | 6.94 | 1.05 | 10.93 | 0.5079 | 0.00 | 14.10 | 2.31 | -45.42 | -- | 4.86 | -- |
| STAAR Surgical Company | 242.92m | 29.11m | 3.96bn | 692.00 | 140.79 | 14.34 | 120.53 | 16.31 | 0.5888 | 0.5888 | 4.91 | 5.78 | 0.7874 | 3.07 | 6.01 | 351,040.50 | 9.44 | 5.83 | 10.79 | 7.08 | 77.70 | 74.44 | 11.98 | 6.98 | 6.20 | 14.51 | 0.0018 | 0.00 | 41.00 | 22.83 | 314.36 | -- | 33.61 | -- |
| ICU Medical Inc | 1.78bn | 5.46m | 3.97bn | 8.50k | 399.12 | 1.91 | 23.24 | 2.23 | 0.4167 | 0.4167 | 78.11 | 87.28 | 0.5571 | 2.69 | 10.57 | 209,495.40 | 0.1709 | 5.01 | 0.1909 | 5.76 | 33.23 | 36.98 | 0.3068 | 5.99 | 1.25 | 2.67 | 0.4424 | 0.00 | 3.56 | 28.25 | 18.72 | 10.33 | 27.02 | -- |
| Inari Medical Inc | 335.63m | -15.01m | 4.38bn | 800.00 | -- | 10.58 | -- | 13.06 | -0.287 | -0.287 | 6.57 | 7.76 | 0.9098 | 1.59 | 8.32 | 419,537.50 | -4.07 | -- | -4.51 | -- | 89.38 | -- | -4.47 | -- | 9.39 | -- | 0.00 | -- | 98.31 | -- | -28.64 | -- | -- | -- |
| Premier Inc | 1.57bn | 262.36m | 4.48bn | 2.60k | 17.81 | 2.00 | 11.41 | 2.84 | 2.13 | 2.13 | 12.82 | 18.93 | 0.4373 | 3.90 | 3.80 | 605,273.10 | 7.37 | 15.80 | 9.67 | 19.54 | 55.97 | 64.20 | 16.85 | 31.72 | 0.7249 | -- | 0.2057 | 5.99 | 32.44 | 8.16 | -56.39 | -20.44 | 2.91 | -- |
Data as of Aug 10 2022. Currency figures normalised to Haemonetics Corp's reporting currency: US Dollar USD
61.79%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Wellington Management Co. LLPas of 31 Mar 2022 | 6.17m | 12.02% |
| Capital Research & Management Co. (Global Investors)as of 31 Mar 2022 | 5.45m | 10.63% |
| BlackRock Fund Advisorsas of 31 Mar 2022 | 5.16m | 10.07% |
| The Vanguard Group, Inc.as of 31 Mar 2022 | 4.79m | 9.35% |
| Neuberger Berman Investment Advisers LLCas of 31 Mar 2022 | 3.77m | 7.35% |
| SSgA Funds Management, Inc.as of 31 Mar 2022 | 1.73m | 3.38% |
| Franklin Advisers, Inc.as of 31 Mar 2022 | 1.46m | 2.85% |
| Fisher Asset Management LLCas of 31 Mar 2022 | 1.19m | 2.32% |
| LGT Capital Partners AG (Investment Management)as of 30 Jun 2022 | 988.15k | 1.93% |
| The London Company of Virginia LLCas of 31 Mar 2022 | 971.01k | 1.89% |
More ▼
Data from 31 Mar 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
